Eaton Vance Management Enanta Pharmaceuticals Inc Transaction History

Eaton Vance Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$56.06 - $74.11 $113,185 - $149,628	-2,019 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$60.19 - $97.37 $66,871 - $108,178	-1,111 Reduced 35.5%	2,019 $71,000
Q3 2021 Nov 15, 2021	BUY	$41.02 - $58.65 $9,475 - $13,548	231 Added 7.97%	3,130 $118,000
Q2 2021 Aug 16, 2021	BUY	$43.76 - $53.11 $24,855 - $30,166	568 Added 24.37%	2,899 $127,000
Q1 2021 May 17, 2021	BUY	$41.69 - $54.95 $97,179 - $128,088	2,331 New	2,331 $115,000
Q3 2018 Nov 13, 2018	SELL	$85.46 - $126.37 $174,338 - $257,794	-2,040 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$81.85 - $120.51 $166,974 - $245,840	2,040 New	2,040 $236,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

Stay updated on Eaton Vance Management with notifications on news.